Stock Earnings

Question 1

What are CureVac NV's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), CureVac NV has a total asset of $802, Net profit of $162

Question 2

What are the key financial ratios for CVAC?

Accepted Answer

CureVac NV's Current ratio is 7.56, has a Net margin is 30.28, sales per share of $2.37.

Question 3

How is CureVac NV's revenue broken down by segment or geography?

Accepted Answer

CureVac NV largest revenue segment is Transformative Medicines, at a revenue of 578,899,253 in the most earnings release.For geography, Belgium is the primary market for CureVac NV, at a revenue of 562,316,933.

Question 4

Is CureVac NV profitable?

Accepted Answer

yes, according to the latest financial statements, CureVac NV has a net profit of $162

Question 5

Does CureVac NV have any liabilities?

Accepted Answer

yes, CureVac NV has liability of 106

Question 6

How many outstanding shares for CureVac NV?

Accepted Answer

CureVac NV has a total outstanding shares of 224.33

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	70	535	53	67	103	48
Revenue Growth (YoY)	-87%	909%	-21%	-35%	114.99%	182%
Cost of Revenue	4	105	116	159	238	14
Gross Profit	65	429	-62	-91	-135	34
Selling, General & Admin	83	66	81	95	93	48
Research & Development	146	141	107	53	811	111
Operating Expenses	-84	251	208	133	343	144
Other Non Operating Income (Expenses)	0	--	--	--	--	--
Pretax Income	157	190	-259	-249	-412	-129
Income Tax Expense	28	28	0	0	0	0
Net Income	128	162	-260	-249	-411	-129
Net Income Growth	19%	-162%	4%	-39%	219%	30%
Shares Outstanding (Diluted)	225.8	225.25	220.48	195	187.1	180.5
Shares Change (YoY)	0%	2%	13%	4%	4%	2%
EPS (Diluted)	0.57	0.72	-1.18	-1.28	-2.2	-0.72
EPS Growth	19%	-161%	-8%	-42%	206%	26%
Free Cash Flow	-125	83	-323	-379	-861	475
Free Cash Flow Per Share	-0.55	0.36	-1.46	-1.94	-4.6	2.63
Gross Margin	92.85%	80.18%	-116.98%	-135.82%	-131.06%	70.83%
Operating Margin	212.85%	33.08%	-509.43%	-335.82%	-464.07%	-227.08%
Profit Margin	182.85%	30.28%	-490.56%	-371.64%	-399.02%	-268.75%
Free Cash Flow Margin	-178.57%	15.51%	-609.43%	-565.67%	-835.92%	989.58%
EBITDA	166	196	-248	-205	-465	-101
EBITDA Margin	237.14%	36.63%	-467.92%	-305.97%	-451.45%	-210.41%
D&A For EBITDA	17	19	22	20	13	8
EBIT	149	177	-270	-225	-478	-109
EBIT Margin	212.85%	33.08%	-509.43%	-335.82%	-464.07%	-227.08%
Effective Tax Rate	17.83%	14.73%	0%	0%	0%	0%

CureVac NV (CVAC) Price

CVAC Stock Price Chart

CVAC Income

Follow-Up Questions